A random mutagenesis screen enriched for missense mutations in bacterial effector proteins
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: G3: Genes, Genomes, Genetics, Vol. 14, No. 9, 04.09.2024.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - A random mutagenesis screen enriched for missense mutations in bacterial effector proteins
AU - Urbanus, Malene L
AU - Zheng, Thomas M
AU - Khusnutdinova, Anna N
AU - Banh, Doreen
AU - O'Connor Mount, Harley
AU - Gupta, Alind
AU - Stogios, Peter J
AU - Savchenko, Alexei
AU - Isberg, Ralph R
AU - Yakunin, Alexander F
AU - Ensminger, Alexander W
N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of The Genetics Society of America.
PY - 2024/9/4
Y1 - 2024/9/4
N2 - To remodel their hosts and escape immune defenses, many pathogens rely on large arsenals of proteins (effectors) that are delivered to the host cell using dedicated translocation machinery. Effectors hold significant insight into the biology of both the pathogens that encode them and the host pathways that they manipulate. One of the most powerful systems biology tools for studying effectors is the model organism, Saccharomyces cerevisiae. For many pathogens, the heterologous expression of effectors in yeast is growth inhibitory at a frequency much higher than housekeeping genes, an observation ascribed to targeting conserved eukaryotic proteins. Abrogation of yeast growth inhibition has been used to identify bacterial suppressors of effector activity, host targets, and functional residues and domains within effector proteins. We present here a yeast-based method for enriching for informative, in-frame, missense mutations in a pool of random effector mutants. We benchmark this approach against three effectors from Legionella pneumophila, an intracellular bacterial pathogen that injects a staggering >330 effectors into the host cell. For each protein, we show how in silico protein modeling (AlphaFold2) and missense-directed mutagenesis can be combined to reveal important structural features within effectors. We identify known active site residues within the metalloprotease RavK, the putative active site in SdbB, and previously unidentified functional motifs within the C-terminal domain of SdbA. We show that this domain has structural similarity with glycosyltransferases and exhibits in vitro activity consistent with this predicted function.
AB - To remodel their hosts and escape immune defenses, many pathogens rely on large arsenals of proteins (effectors) that are delivered to the host cell using dedicated translocation machinery. Effectors hold significant insight into the biology of both the pathogens that encode them and the host pathways that they manipulate. One of the most powerful systems biology tools for studying effectors is the model organism, Saccharomyces cerevisiae. For many pathogens, the heterologous expression of effectors in yeast is growth inhibitory at a frequency much higher than housekeeping genes, an observation ascribed to targeting conserved eukaryotic proteins. Abrogation of yeast growth inhibition has been used to identify bacterial suppressors of effector activity, host targets, and functional residues and domains within effector proteins. We present here a yeast-based method for enriching for informative, in-frame, missense mutations in a pool of random effector mutants. We benchmark this approach against three effectors from Legionella pneumophila, an intracellular bacterial pathogen that injects a staggering >330 effectors into the host cell. For each protein, we show how in silico protein modeling (AlphaFold2) and missense-directed mutagenesis can be combined to reveal important structural features within effectors. We identify known active site residues within the metalloprotease RavK, the putative active site in SdbB, and previously unidentified functional motifs within the C-terminal domain of SdbA. We show that this domain has structural similarity with glycosyltransferases and exhibits in vitro activity consistent with this predicted function.
KW - Bacterial Proteins/genetics
KW - Mutagenesis
KW - Mutation, Missense
KW - Saccharomyces cerevisiae/genetics
KW - Legionella pneumophila/genetics
KW - Models, Molecular
U2 - 10.1093/g3journal/jkae158
DO - 10.1093/g3journal/jkae158
M3 - Article
C2 - 39028840
VL - 14
JO - G3: Genes, Genomes, Genetics
JF - G3: Genes, Genomes, Genetics
SN - 2160-1836
IS - 9
ER -